These results, together with our recent findings[37], help to explain why mice doubly deficient for p53 and p16INK4a exhibited an increased rate of tumor formation [61,62], and why the combination of p53 and p16INK4a loss is frequently observed in human cancer cells [63]. The gene discussed is CDKN2A; the disease is neoplasm.